CETP Inhibitors - A New Inning?
作者信息
Hegele Robert A
机构信息
From the Department of Medicine, Schulich School of Medicine and Dentistry, London, ON, Canada.
出版信息
N Engl J Med. 2017 Sep 28;377(13):1284-1285. doi: 10.1056/NEJMe1711407.
PMID:28953440
Abstract
摘要
相似文献
1
CETP Inhibitors - A New Inning?胆固醇酯转运蛋白抑制剂——新的契机？
N Engl J Med. 2017 Sep 28;377(13):1284-1285. doi: 10.1056/NEJMe1711407.
2
Effects of cholesteryl ester transfer protein inhibitors on human lipoprotein metabolism: why have they failed in lowering coronary heart disease risk?胆固醇酯转移蛋白抑制剂对人体脂蛋白代谢的影响：为何它们未能降低冠心病风险？
Curr Opin Lipidol. 2013 Jun;24(3):259-64. doi: 10.1097/MOL.0b013e3283612454.
3
Refocusing on use of cholesteryl ester transfer protein inhibitors.重新聚焦胆固醇酯转运蛋白抑制剂的应用。
Am J Cardiol. 2007 Dec 3;100(11 A):n47-52. doi: 10.1016/j.amjcard.2007.08.013.
4
Future of cholesteryl ester transfer protein inhibitors.胆固醇酯转移蛋白抑制剂的未来。
Annu Rev Med. 2014;65:385-403. doi: 10.1146/annurev-med-050311-163305.
5
Increasing high-density lipoprotein cholesterol, inhibition of cholesteryl ester transfer protein, and heart disease risk reduction.提高高密度脂蛋白胆固醇、抑制胆固醇酯转运蛋白与降低心脏病风险
Am J Cardiol. 2007 Dec 3;100(11 A):n25-31. doi: 10.1016/j.amjcard.2007.08.010.
6
[HDL and CETP in atherogenesis].[高密度脂蛋白与胆固醇酯转运蛋白在动脉粥样硬化发生中的作用]
Dtsch Med Wochenschr. 2010 Feb;135(5):188-92. doi: 10.1055/s-0030-1247862. Epub 2010 Jan 15.
7
Anacetrapib, but not evacetrapib, impairs endothelial function in CETP-transgenic mice in spite of marked HDL-C increase.尽管 CETP 转基因小鼠的 HDL-C 显著增加，但阿昔单抗而不是依维司他可损害其内皮功能。
Atherosclerosis. 2017 Feb;257:186-194. doi: 10.1016/j.atherosclerosis.2017.01.011. Epub 2017 Jan 16.
8
CETP inhibitors to increase HDL cholesterol levels.胆固醇酯转运蛋白抑制剂可提高高密度脂蛋白胆固醇水平。
N Engl J Med. 2007 Mar 29;356(13):1364-6. doi: 10.1056/NEJMe078029. Epub 2007 Mar 26.
9
Inhibition of cholesteryl ester transfer protein increases cholesteryl ester content of large HDL independently of HDL-to-HDL homotypic transfer: in vitro vs in vivo comparison using anacetrapib and dalcetrapib.抑制胆固醇酯转运蛋白可增加大型高密度脂蛋白（HDL）的胆固醇酯含量，且与HDL间的同型转运无关：使用阿那曲匹和达塞曲匹进行的体外与体内比较
Eur J Pharmacol. 2015 Sep 5;762:256-62. doi: 10.1016/j.ejphar.2015.05.061. Epub 2015 Jun 3.
10
[Treatment of dyslipidemia - is here still place for CETP-inhibitors?].[血脂异常的治疗——CETP抑制剂还有用吗？]
Vnitr Lek. 2016 Fall;62(10):789-794.
引用本文的文献
1
Highly Chemoselective Synthesis of Azaarene-Equipped CF-Tertiary Alcohols under Metal-Free Conditions and Their Fungicidal Activities.无金属条件下氮杂芳烃取代的CF-叔醇的高化学选择性合成及其杀菌活性
ACS Omega. 2022 Oct 10;7(42):38084-38093. doi: 10.1021/acsomega.2c05855. eCollection 2022 Oct 25.
2
Pulmonary surfactant protein B carried by HDL predicts incident CVD in patients with type 1 diabetes.高密度脂蛋白携带的肺表面活性物质蛋白B可预测1型糖尿病患者发生心血管疾病的风险。
J Lipid Res. 2022 Apr;63(4):100196. doi: 10.1016/j.jlr.2022.100196. Epub 2022 Mar 14.
3
Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target.载脂蛋白B与心血管疾病：生物标志物及潜在治疗靶点
Metabolites. 2021 Oct 8;11(10):690. doi: 10.3390/metabo11100690.
4
A New Equation Based on the Standard Lipid Panel for Calculating Small Dense Low-Density Lipoprotein-Cholesterol and Its Use as a Risk-Enhancer Test.一种基于标准脂质谱计算小而密低密度脂蛋白胆固醇的新方程及其作为风险增强试验的应用。
Clin Chem. 2021 Jul 6;67(7):987-997. doi: 10.1093/clinchem/hvab048.
5
Integration of Transformative Platforms for the Discovery of Causative Genes in Cardiovascular Diseases.转化平台在心血管疾病致病基因发现中的整合。
Cardiovasc Drugs Ther. 2021 Jun;35(3):637-654. doi: 10.1007/s10557-021-07175-1. Epub 2021 Apr 15.
6
β-Carotene Oxygenase 1 Activity Modulates Circulating Cholesterol Concentrations in Mice and Humans.β-胡萝卜素加氧酶 1 活性调节小鼠和人类循环胆固醇浓度。
J Nutr. 2020 Aug 1;150(8):2023-2030. doi: 10.1093/jn/nxaa143.
7
Genetic determinants of blood lipids and cerebral small vessel disease: role of high-density lipoprotein cholesterol.血脂和脑小血管病的遗传决定因素：高密度脂蛋白胆固醇的作用。
Brain. 2020 Feb 1;143(2):597-610. doi: 10.1093/brain/awz413.
8
Management of Hyperlipidemia After Stroke.卒中后高脂血症的管理
Curr Treat Options Cardiovasc Med. 2019 Dec 16;21(12):93. doi: 10.1007/s11936-019-0774-8.
9
Albuminuria, the High-Density Lipoprotein Proteome, and Coronary Artery Calcification in Type 1 Diabetes Mellitus.1 型糖尿病患者的蛋白尿、高密度脂蛋白蛋白质组与冠状动脉钙化
Arterioscler Thromb Vasc Biol. 2019 Jul;39(7):1483-1491. doi: 10.1161/ATVBAHA.119.312556. Epub 2019 May 16.
10
High-Density Lipoprotein Function and Dysfunction in Health and Disease.高密度脂蛋白的功能和异常在健康和疾病中的作用。
Cardiovasc Drugs Ther. 2019 Apr;33(2):207-219. doi: 10.1007/s10557-018-06846-w.
Zotero 插件